Journal of Cancer Metastasis and Treatment is Selected to be Included in Emerging Sources Citation Index（ESCI）

The Editorial Office of the Journal of Cancer Metastasis and Treatment (JCMT) is pleased to announce that JCMT is selected to be included in Emerging Sources Citation Index (ESCI, Web of Science)on December 12, 2022, which is a new milestone for JCMT in 2022. Publications of JCMT from 2020 will be fully indexed in the Core Collection of Web of Science.

Journals indexed in ESCI are selected by the Clarivate editorial staff based on their high publishing standards, high-quality editorial content, and citation metrics from the Web of Science. These journals have passed an initial editorial evaluation and can continue to be considered for inclusion in products such as SCIE, SSCI, and AHCI, which have rigorous evaluation processes and selection criteria.

The Editorial Office thanks to all Editorial Board members, authors, reviewers, and readers who gave their great supports and contributions to JCMT over the past years. We will continue publishing high-quality articles, promoting academic exchanges and accelerating the research progress of the field of cancer metastasis and treatment.

About JCMT:
Journal of Cancer Metastasis and Treatment is an international peer-reviewed, gold open access, online academic journal founded by OAE Publishing Inc. in 2015. The journal aims to provide the best academic sharing and exchange platform in cancer metastasis and treatment, including the occurrence, development, progression, metastasis, and treatment of neoplastic diseases. The journal is indexed in ESCI, Scopus, CAS, Wanfang Data, CNKI, Dimensions, and Google Scholar.

Journal website: https://oaepublish.com/jcmt
Online submission: https://oaemesas.com/login?JournalId=jcmt